| Product Code: ETC070063 | Publication Date: Jun 2023 | Updated Date: Jun 2026 | Product Type: Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 |
The India Biobanking Market was estimated at USD 696 Million in 2025 and is projected to reach USD 990 Million by 2032, growing at a CAGR of 5.2% from 2026 to 2032. This growth trajectory is primarily driven by the rising prevalence of chronic diseases in India, which necessitates extensive research and sample collection. Additionally, increasing government support and investment in healthcare infrastructure are further enhancing the biobanking landscape in the country.
This graph highlights how the India Biobanking Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market
| Year | Growth Rate | Major Drivers |
| 2021 | -2.9% | Increasing smart city development projects |
| 2022 | 8.9% | Expansion of commercial construction activities |
| 2023 | 8.0% | Increasing industrial infrastructure investments |
| 2024 | 7.5% | Rising electricity demand across industries |
| 2025 | 7.0% | Increasing industrial infrastructure investments |
| 2026 | 7.5% | Government infrastructure modernization initiatives |
| 2027 | 6.1% | Expansion of transportation and logistics networks |
| 2028 | 5.9% | Expansion of transportation and logistics networks |
| 2029 | 6.1% | Increasing smart city development projects |
| 2030 | 6.5% | Increasing adoption of advanced technologies |
| 2031 | 6.0% | Growing urbanization and commercial development |
| 2032 | 6.1% | Rapid growth in telecom and data center sectors |
Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.
India's biobanking market is rapidly evolving, becoming a pivotal player in the global biomedical research scene. With advancements in personalized medicine, there is a growing demand for biological samples that can provide critical insights into disease mechanisms and treatment responses.
The landscape is also shaped by significant investments in technology and infrastructure, encouraging both public and private sector collaborations. This synergy not only enhances the quality of biobanking practices but also facilitates the integration of big data analytics and AI, further propelling the market's expansion.
Despite the positive growth indicators, the India Biobanking Market faces several substantial challenges. The high costs associated with establishing and maintaining biobanks can deter investment, particularly for smaller entities. Additionally, there is a pronounced shortage of skilled personnel who can effectively manage biobanking operations. Concerns over data privacy and regulatory hurdles further complicate the landscape, as do inadequate funding mechanisms for ongoing research activities. Furthermore, the lack of standardization across biobanking practices impedes consistency and quality.
The market is witnessing several transformative trends. There is a marked shift towards strategic collaborations between private companies and public institutions, which enhances resource pooling and research opportunities. The adoption of digitalized systems and advancements in sample preservation technologies are streamlining operations, while big data analytics and predictive modeling are enhancing data utilization. Additionally, the emergence of blockchain technology is providing new avenues for ensuring sample integrity and data security, aligning with global standards.
Opportunities within the India Biobanking Market are abundant, particularly for companies looking to leverage technological innovations. There is significant potential in developing customized biobanking solutions tailored to specific research needs, which can enhance the value of biosamples. Furthermore, the increasing awareness and demand for personalized medicine present an avenue for growth, as stakeholders seek to capitalize on genomic research. Expanding biobanks into underserved regions could also improve access to biological samples, promoting inclusive healthcare research.
The Indian government has been proactive in bolstering the biobanking sector through various initiatives aimed at improving healthcare infrastructure. Programs designed to provide tax incentives on research and development expenditures are encouraging investment. Additionally, the government is fostering an environment conducive to innovation by promoting collaborations between academic institutions and private sector players. These initiatives are crucial in nurturing a sustainable ecosystem for biobanking, enhancing research capabilities, and ultimately improving healthcare outcomes.
Looking ahead to 2026-2032, the India Biobanking Market is poised for substantial growth driven by the ongoing evolution of healthcare needs. As chronic diseases become more prevalent, the demand for biosamples will continue to rise, leading to increased investment in biobanks. Furthermore, advancements in technology, particularly in data analytics and storage solutions, will enhance operational efficiency and sample integrity. The focus on personalized medicine is expected to solidify biobanking’s role in research and clinical applications, underscoring its significance in the future landscape of Indian healthcare.
In recent months, the India biobanking sector has seen a surge in technological advancements, particularly in digital management systems that streamline operations. Collaborations between public health organizations and private biobanks are being established to enhance research capabilities and accessibility of biosamples. Furthermore, ongoing discussions around regulatory frameworks are highlighting the need for standardized practices, which could pave the way for greater operational efficiency and transparency in biobanking.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Biobanking Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Biobanking Market Revenues & Volume, 2022 & 2032F |
3.3 India Biobanking Market - Industry Life Cycle |
3.4 India Biobanking Market - Porter's Five Forces |
3.5 India Biobanking Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 India Biobanking Market Revenues & Volume Share, By Applications, 2022 & 2032F |
3.7 India Biobanking Market Revenues & Volume Share, By Sample Type, 2022 & 2032F |
4 India Biobanking Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India, leading to a higher demand for personalized medicine and research. |
4.2.2 Growing awareness about the importance of preserving biological samples for medical research and advancements. |
4.2.3 Government initiatives and funding to support biobanking infrastructure development in India. |
4.3 Market Restraints |
4.3.1 Lack of standardized regulations and guidelines for biobanking practices in India, leading to concerns about sample quality and integrity. |
4.3.2 Limited investment in research and development of biobanking technologies and facilities. |
4.3.3 Challenges in maintaining sample quality and integrity due to inadequate storage and handling facilities. |
5 India Biobanking Market Trends |
6 India Biobanking Market, By Types |
6.1 India Biobanking Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Biobanking Market Revenues & Volume, By Type, 2022-2032F |
6.1.3 India Biobanking Market Revenues & Volume, By Equipment, 2022-2032F |
6.1.4 India Biobanking Market Revenues & Volume, By Consumables, 2022-2032F |
6.1.5 India Biobanking Market Revenues & Volume, By Services, 2022-2032F |
6.1.6 India Biobanking Market Revenues & Volume, By Software, 2022-2032F |
6.2 India Biobanking Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 India Biobanking Market Revenues & Volume, By Regenerative Medicine, 2022-2032F |
6.2.3 India Biobanking Market Revenues & Volume, By Life Science Research, 2022-2032F |
6.2.4 India Biobanking Market Revenues & Volume, By Clinical Research, 2022-2032F |
6.3 India Biobanking Market, By Sample Type |
6.3.1 Overview and Analysis |
6.3.2 India Biobanking Market Revenues & Volume, By Blood Products, 2022-2032F |
6.3.3 India Biobanking Market Revenues & Volume, By Human Tissues, 2022-2032F |
6.3.4 India Biobanking Market Revenues & Volume, By Nucleic Acids, 2022-2032F |
6.3.5 India Biobanking Market Revenues & Volume, By Cell Lines, 2022-2032F |
6.3.6 India Biobanking Market Revenues & Volume, By Biological Fluids, 2022-2032F |
6.3.7 India Biobanking Market Revenues & Volume, By Human Waste Products, 2022-2032F |
7 India Biobanking Market Import-Export Trade Statistics |
7.1 India Biobanking Market Export to Major Countries |
7.2 India Biobanking Market Imports from Major Countries |
8 India Biobanking Market Key Performance Indicators |
8.1 Number of collaborations between biobanks, research institutions, and healthcare organizations. |
8.2 Percentage of biobanks in India accredited by regulatory bodies for maintaining quality standards. |
8.3 Rate of adoption of advanced biobanking technologies and automation in sample processing and storage. |
8.4 Number of research publications citing data obtained from Indian biobanks. |
8.5 Percentage increase in the number of samples stored in Indian biobanks over time. |
9 India Biobanking Market - Opportunity Assessment |
9.1 India Biobanking Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 India Biobanking Market Opportunity Assessment, By Applications, 2022 & 2032F |
9.3 India Biobanking Market Opportunity Assessment, By Sample Type, 2022 & 2032F |
10 India Biobanking Market - Competitive Landscape |
10.1 India Biobanking Market Revenue Share, By Companies, 2025 |
10.2 India Biobanking Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here